-+ 0.00%
-+ 0.00%
-+ 0.00%

B of A Securities Maintains Neutral on Pfizer, Lowers Price Target to $26

Benzinga·07/10/2026 18:07:53
Listen to the news
B of A Securities analyst Jason Gerberry maintains Pfizer (NYSE:PFE) with a Neutral and lowers the price target from $27 to $26.